OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj, Ramasamy Thangavel, Deepak D. Kempuraj, et al.
BioFactors (2020) Vol. 47, Iss. 2, pp. 190-197
Closed Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

The role of plant‐derived natural antioxidants in reduction of oxidative stress
Behnaz Akbari, Namdar Baghaei‐Yazdi, Manochehr Bahmaie, et al.
BioFactors (2022) Vol. 48, Iss. 3, pp. 611-633
Closed Access | Times Cited: 336

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 128

Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation
Jiejian Kou, Jun-Zhuo Shi, Yangyang He, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 840-849
Open Access | Times Cited: 122

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 53

Flavonoids improve type 2 diabetes mellitus and its complications: a review
Xinrui Yi, Mosi Dong, Naifei Guo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 48

Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
Chenhao Yao, Shu Dai, Cheng Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115464-115464
Open Access | Times Cited: 42

Luteolin: A promising multifunctional natural flavonoid for human diseases
Mingtao Zhu, Yanping Sun, Yang Su, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3417-3443
Open Access | Times Cited: 31

Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
Shuang Chai, Yanbing Yang, Liwei Wei, et al.
Phytomedicine (2024) Vol. 128, pp. 155516-155516
Open Access | Times Cited: 20

Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 110

Luteolin Alleviates AflatoxinB1-Induced Apoptosis and Oxidative Stress in the Liver of Mice through Activation of Nrf2 Signaling Pathway
Shahid Ali Rajput, Aftab Shaukat, Kuntan Wu, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1268-1268
Open Access | Times Cited: 71

Targeting Nrf2-Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals
Anguo Wu, Yuan-Yuan Yong, Yi-Ru Pan, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 58

Luteolin Attenuates Hypertension via Inhibiting NF-κB-Mediated Inflammation and PI3K/Akt Signaling Pathway in the Hypothalamic Paraventricular Nucleus
Hong‐Li Gao, Xiao‐Jing Yu, Yu‐Qi Feng, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 502-502
Open Access | Times Cited: 29

COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions
Duraisamy Kempuraj, Kristina Aenlle, Jessica R. Cohen, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 421-439
Closed Access | Times Cited: 29

Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence
Giuliana La Rosa, Maria Serena Lonardo, Nunzia Cacciapuoti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7247-7247
Open Access | Times Cited: 23

Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 23

Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 15

Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease
Lorenza Guarnieri, Francesca Bosco, Antonio Leo, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102210-102210
Open Access | Times Cited: 13

Flavonoids derived from medicinal plants as a COVID‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8

Brain‐targeting drug delivery systems
Peixin Liu, Chen Jiang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 5
Closed Access | Times Cited: 35

Applications of Perilla frutescens Extracts in Clinical Practice
G. Shedden Adam, Silvia Robu, Mihaela-Magdalena Flutur, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 727-727
Open Access | Times Cited: 20

Page 1 - Next Page

Scroll to top